Sickle Cell Disease Severity Prediction from Percoll Gradient Images Using Graph Convolutional Networks

Ario Sadafi, Asya Makhro, Leonid Livshits, Nassir Navab, Anna Bogdanova, Shadi Albarqouni, Carsten Marr

Abstract

Sickle Cell Disease (SCD) is a genetic disorder characterized by unpredictable clinical severity. Traditional assessment of disease severity relies on expensive laboratory measurements of hemoglobin density, which are often unavailable in low-resource settings. This paper presents SCD-severity-GCN, a deep learning pipeline that predicts SCD severity using accessible data: images of Percoll density gradients and basic ultrasound measurements. By leveraging Graph Convolutional Networks (GCNs) to model patient similarities and a hybrid feature extraction method, the proposed model achieves performance comparable to methods utilizing high-end laboratory equipment.

Introduction

Sickle Cell Disease (SCD) causes red blood cells (RBCs) to become rigid and sickle-shaped, leading to severe complications such as vaso-occlusive crises and organ damage. A key biomarker for severity is the presence of hypochromic (low hemoglobin) and hyperchromic (dense) cells. However, quantifying these cells requires automated cell counters and specialized tests that are scarce in high-prevalence, low-resource regions.

Percoll density gradients offer a cost-effective alternative by separating cells by density into visible bands. However, manual interpretation of these gradients is subjective and difficult. This research aims to automate this process, providing a reliable severity score (1-4) using only a centrifuge, a camera, and basic clinical data like spleen size.

Methods

The authors developed a multi-stage pipeline, SCD-severity-GCN, to translate Percoll images into clinical predictions.

Feature Extraction and Proxy Estimation

To capture the unique visual characteristics of Percoll gradients, the model employs a hybrid CNN-FFT approach. A standard CNN (AlexNet) extracts textural features, while a Fast Fourier Transform (FFT) captures the periodic banding patterns of cells. Crucially, to maintain independence from expensive lab tests, a separate CNN was trained to estimate the percentage of hypo- and hyperchromic cells directly from the images.

Population Graph and GCN

Instead of processing samples in isolation, the model constructs a population graph where each node represents a patient sample. Edges are weighted based on similarity in spleen size (obtained via ultrasound) and the estimated hemoglobin density. A Graph Convolutional Network (GCN) then processes this graph, allowing the model to refine predictions by considering the clinical profiles of similar patients.

Overview of the SCD-severity-GCN pipeline, illustrating feature extraction, similarity calculation, and graph convolutional layers.

Results

The study utilized 216 samples from 17 patients diagnosed with SCD, with ground-truth severity determined by the Sebastiani scale. The SCD-severity-GCN achieved an accuracy of 0.61, significantly outperforming traditional machine learning baselines like Support Vector Machines (accuracy < 0.45).

Performance Benchmarking

A key finding was the small performance gap between the image-only model and an "upper bound" model (GCN-Lab) that used actual laboratory measurements (accuracy 0.65). This suggests that the proxy estimation of hemoglobin density from images is highly effective, making the system viable for clinics without high-end lab equipment.

Feature Disentanglement

Visualization of the high-dimensional features using UMAP embeddings demonstrates the GCN's ability to cluster samples by severity. While raw image features appear scattered, the GCN-processed features show clear separation between severity classes, indicating successful feature disentanglement.

UMAP visualizations comparing raw feature vectors, the proposed SCD-severity-GCN, and the GCN-Lab upper bound, showing improved class separation.

Discussion and Conclusion

The proposed method demonstrates that deep learning can bridge the gap between low-cost diagnostic tools and high-end laboratory analysis. By automating the interpretation of Percoll gradients and incorporating clinical similarity through graph networks, the system provides a robust tool for SCD severity assessment.

The primary limitation of this study is the small patient cohort (17 patients), which may lead to overfitting. Future work will focus on expanding the dataset to include more diverse cases, particularly pediatric data, and refining the severity scale toward a continuous prediction model. This approach holds significant promise for improving SCD management in underserved regions.

Summary updated

Abstract

Sickle cell disease (SCD) is a severe genetic hemoglobin disorder that results in premature destruction of red blood cells. Assessment of the severity of the disease is a challenging task in clinical routine since the causes of broad variance in SCD manifestation despite the common genetic cause remain unclear. Identification of the biomarkers that would predict the severity grade is of importance for prognosis and assessment of responsiveness of patients to therapy. Detection of the changes in red blood cell (RBC) density through separation of Percoll density gradient could be such marker as it allows to resolve intercellular differences and follow the most damaged dense cells prone to destruction and vaso-occlusion. Quantification of the images obtained from the distribution of RBCs in Percoll gradient and interpretation of the obtained is an important prerequisite for establishment of this approach. Here, we propose a novel approach combining a graph convolutional network, a convolutional neural network, fast Fourier transform, and recursive feature elimination to predict the severity of SCD directly from a Percoll image. Two important but expensive laboratory blood test parameters measurements are used for training the graph convolutional network. To make the model independent from such tests during prediction, the two parameters are estimated by a neural network from the Percoll image directly. On a cohort of 216 subjects, we achieve a prediction performance that is only slightly below an approach where the groundtruth laboratory measurements are used. Our proposed method is the first computational approach for the difficult task of SCD severity prediction. The two-step approach relies solely on inexpensive and simple blood analysis tools and can have a significant impact on the patients' survival in underdeveloped countries where access to medical instruments and doctors is limited
BibTeX
@inproceedings{sadafi2021sickle,
  author = {Ario Sadafi and Asya Makhro and Leonid Livshits and Nassir Navab and Anna Bogdanova and Shadi Albarqouni and Carsten Marr},
  title = {{Sickle Cell Disease Severity Prediction from Percoll Gradient Images Using Graph Convolutional Networks}},
  booktitle = {DART/FAIR @ MICCAI},
  year = {2021},
  doi = {10.1007/978-3-030-87722-4\_20},
}
Figure